Therefore, we concluded that D2 and NANOG are specifically expressed in the tumor epithelium of BCC and not in the CD34+ population of CSCs and that the expression of D2 and NANOG in CSCs drastically differs from that in the bulk of tumors. The gene discussed is CD34; the disease is skin basal cell carcinoma.